Asset Allocation

As of January 31, 2026.
Type % Net
Cash 7.91%
Stock 69.27%
Bond 23.79%
Convertible 0.00%
Preferred 0.00%
Other -0.97%
View Asset Allocation
Start Trial

Market Capitalization

As of January 31, 2026
Large 78.36%
Mid 16.33%
Small 5.31%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 101.0%    % Emerging Markets: 0.00%    % Unidentified Markets: -0.97%

Americas 71.52%
71.52%
Canada 7.91%
United States 63.61%
0.00%
As of January 31, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 21.87%
United Kingdom 4.53%
15.27%
France 1.42%
Germany 1.99%
Italy 1.52%
Netherlands 1.82%
Spain 1.49%
Switzerland 5.62%
0.00%
2.07%
Israel 2.07%
Greater Asia 7.58%
Japan 2.79%
0.00%
4.79%
Hong Kong 1.52%
Singapore 1.35%
Taiwan 1.92%
0.00%
Unidentified Region -0.97%

Bond Credit Quality Exposure

AAA 0.00%
AA 100.0%
A 0.00%
BBB 0.00%
BB 0.00%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 0.00%
Short Term 0.00%
As of January 31, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
34.57%
Materials
6.67%
Consumer Discretionary
3.92%
Financials
23.98%
Real Estate
0.00%
Sensitive
53.72%
Communication Services
5.67%
Energy
6.30%
Industrials
18.66%
Information Technology
23.10%
Defensive
11.71%
Consumer Staples
0.00%
Health Care
11.71%
Utilities
0.00%
Not Classified
0.00%
Non Classified Equity
0.00%
Not Classified - Non Equity
0.00%
As of January 31, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of January 31, 2026
Type % Net
Government 100.0%
Corporate 0.00%
Securitized 0.00%
Municipal 0.00%
Other 0.00%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
0.00%
Less than 1 Year
0.00%
Intermediate
100.0%
1 to 3 Years
32.54%
3 to 5 Years
0.00%
5 to 10 Years
67.46%
Long Term
0.00%
10 to 20 Years
0.00%
20 to 30 Years
0.00%
Over 30 Years
0.00%
Other
0.00%
As of January 31, 2026
View Bond Maturity Exposure
Start Trial